혈관내 체온 관리 시장 보고서 : 유형, 제품 유형, 용도, 지역별(2026-2034년)

The global intravascular temperature management market size reached USD 348.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 441.4 Million by 2034, exhibiting a growth rate (CAGR) of 2.59% during 2026-2034. The growing geriatric population, which is at a higher risk of developing critical conditions, rising prevalence of cardiovascular and neurological conditions, including cardiac arrest, stroke, and traumatic brain injuries, and increasing cases of cancer are some of the factors impelling the market growth.

Intravascular temperature management is a safe and effective method of controlling the core temperature of the patient's body. It relies on a closed-circuit catheter for circulating cold or hot saline to the blood during therapeutic hypothermia. It offers several advantages, such as reduced nursing time and stay in the hospital, immediate availability of triple lumen access, and saving critical time in intensive care units. It is used to prevent neurological damage after cardiac arrest as it decreases complications, such as neurologic injury, compared to conventional methods. In addition, it finds applications in surgical centers, emergency care units, and ambulatory surgical centers worldwide.

Intravascular Temperature Management Market Trends:

Presently, there is a rise in the prevalence of cardiovascular diseases among the masses due to obesity, stress, excessive smoking, and lack of physical activities. This, along with the growing demand for intravascular temperature management for post-cardiac conditions, represents one of the key factors driving the market. Moreover, there is an increase in the adoption of technologically advanced devices in the healthcare industry across the globe. This, coupled with the rising number of surgical centers, is propelling the growth of the market. In addition, the growing awareness among individuals about the benefits of intravascular temperature management, such as reduced morbidity and mortality rate of hospitalized patients, is positively influencing the market around the world. Other growth-inducing factors offering a lucrative outlook for the market are the burgeoning healthcare industry, the rising geriatric population, and the increasing prevalence of neurological disorders. The rising number of clinical studies focusing on the effectiveness of intravascular temperature management systems is projected to bolster the growth of the market.

Market Segmentation:

This report provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. The report categorizes the market based on type, product, application, and end user.

Breakup by Type:

• Intravascular Cooling
• Intravascular Warming

Breakup by Product:

• Systems
• Consumables

Breakup by Application:

• Preoperative Care
• Operative Care
• Post-Operative Care
• Acute and Critical Care

Breakup by End User:

• Surgical Centers
• Emergency Care Units
• Ambulatory Surgical Centers
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Asahi Kasei Corporation, Belmont Instrument Corporation, Biegler GmbH, Gentherm Incorporated, Geratherm Medical AG, Koninklijke Philips N.V., Medtronic plc, Smiths Medical Inc. (ICU Medical Inc.), Stryker Corporation, The Surgical Company B.V, and Vyaire Medical Inc.

Key Questions Answered in This Report:

• How has the global intravascular temperature management market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global market?
• What is the impact of each driver, restraint, and opportunity on the global market?
• What are the key regional markets?
• Which countries represent the most attractive market?
• What is the breakup of the market based on the type?
• Which is the most attractive type in the market?
• What is the breakup of the market based on the product?
• Which is the most attractive product in the market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the market?
• What is the competitive structure of the market?
• Who are the key players/companies in the global intravascular temperature management market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Intravascular Temperature Management Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Intravascular Cooling
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Intravascular Warming
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast

7 Market Breakup by Product

• 7.1 Systems
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Consumables
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Preoperative Care
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Operative Care
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Post-Operative Care
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Acute and Critical Care
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Surgical Centers
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Emergency Care Units
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Ambulatory Surgical Centers
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 3M Company
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Asahi Kasei Corporation
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
    • 15.3.2.3 Financials
    • 15.3.2.4 SWOT Analysis
  • 15.3.3 Belmont Instrument Corporation
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
  • 15.3.4 Biegler GmbH
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Gentherm Incorporated
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
  • 15.3.6 Geratherm Medical AG
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
  • 15.3.7 Koninklijke Philips N.V.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Medtronic plc
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Smiths Medical Inc. (ICU Medical Inc.)
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 SWOT Analysis
  • 15.3.10 Stryker Corporation
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 The Surgical Company B.V.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio
  • 15.3.12 Vyaire Medical Inc.
    • 15.3.12.1 Company Overview
    • 15.3.12.2 Product Portfolio